Bill Title: Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.

Spectrum: Partisan Bill (Democrat 4-0)

Status: (Introduced - Dead) 2024-05-15 - REPORTED AND COMMITTED TO FINANCE [S04513 Detail]

Text: Latest bill text (Introduced) [HTML]

---

Voting Records

Chamber	Vote	Date	Yea	Nay	NV	Abs	Total	Result	Source	View
Senate	Senate Health Committee Vote	2024-05-15	13	2	0	0	15	Passed	Link	View
Senate	Senate Health Committee Vote	2023-05-17	13	2	0	0	15	Passed	Link	View

Social Comments on NY S04513